Anouk M Kesselring

CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater

Luuk Gras, Anouk M Kesselring, James T. Griffin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 165 citations · Full text

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort

S.F.L. van Lelyveld, Luuk Gras, Anouk M Kesselring et al. · AIDS · 2011 · 112 citations

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

Anouk M Kesselring, Ferdinand W N M Wit, Caroline Sabin et al. · AIDS · 2009 · 83 citations

Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy

Shuangjie Zhang, Ard van Sighem, Anouk M Kesselring et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 37 citations

Risk of non‐<scp>AIDS</scp>‐defining events among <scp>HIV</scp>‐infected patients not yet on antiretroviral therapy

S Zhang, Ard van Sighem, Anouk M Kesselring et al. · HIV Medicine · 2015 · 15 citations · Full text